Research
Menopausal women who received hormone therapy for at least five years had a lower risk of Alzheimer's disease and other types of dementia, according to a recent study published in JAMA Internal Medicine.
Over 27,000 postmenopausal women were tracked by the study for more than six years. The study began with women between the ages of 50 and 79, and it followed them until they were 85 years old. 1,438 women experienced the onset of Alzheimer's or another form of dementia during the follow-up period.
In comparison to women who never received hormone therapy, the researchers discovered that the risk of dementia was 24% lower in women who received hormone therapy for five years or longer. Even after the researchers took into account additional variables that may influence the risk of dementia, such as age, educational attainment, and medical conditions like diabetes and high blood pressure, they still came to the same conclusion.
These results imply that hormone therapy may aid in preventing the onset of dementia and other brain disorders like Alzheimer's. It's crucial to keep in mind that since this research was observational, it cannot conclusively show that hormone therapy reduces the risk of dementia. These results need to be confirmed by additional research.
Discuss the potential advantages and disadvantages of hormone therapy with your doctor if you're thinking about starting it during menopause.